SCA
HALO icon

Snowden Capital Advisors’s Halozyme HALO Stock Holding History

Snowden Capital Advisors’s Portfolio HALO Stock Details HALO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-3,720
Closed -$237K – 1233
2025
Q1 		$237K Buy
+3,720
New +$216K 0.01% 1092

Other funds holding HALO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
SCM
Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Snowden Capital Advisors's HALO Position: Q2 2025 in Review

Snowden Capital Advisors sold out of Halozyme (HALO) in Q2 2025, closing a stake of 3,720 shares — an estimated $237K sold.

Snowden Capital Advisors first reported a position in HALO in Q1 2025 and held it in 1 quarter. The position peaked at $237K in Q1 2025. 551 funds tracked by Wall St. Rank hold HALO as of Q2 2025.

  • Snowden Capital Advisors reported no remaining Halozyme position as of Q2 2025 after selling out during the quarter.
  • Snowden Capital Advisors sold 3,720 Halozyme shares in Q2 2025, an estimated $237K.
  • Snowden Capital Advisors first reported a position in Halozyme in Q1 2025 and held it in 1 quarter.
  • Snowden Capital Advisors's Halozyme position peaked at $237K in Q1 2025.
  • 551 funds tracked by Wall St. Rank held Halozyme as of Q2 2025.

Based on Snowden Capital Advisors's 13F filing for Q2 2025, filed 14 Aug 2025.